![]() |
市場調查報告書
商品編碼
1986438
機械人工呼吸器市場報告:按產品類型、介面、年齡層、通氣模式、最終用途和地區分類(2026-2034 年)Mechanical Ventilators Market Report by Product Type, Interface, Age Group, Mode of Ventilation, End-Use, and Region 2026-2034 |
||||||
2025年全球機械人工呼吸器市場規模達59億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到83億美元,2026年至2034年的複合年成長率為3.70% 。成長要素包括慢性阻塞性肺病(COPD)和其他呼吸系統疾病的盛行率不斷上升,高血壓、糖尿病和心血管疾病患者人數不斷增加,以及非侵入性和攜帶式機械人工呼吸器等技術的持續進步。
慢性呼吸系統疾病病例增加
慢性呼吸系統疾病(如氣喘、慢性阻塞型肺疾( COPD)和肺炎)病例的不斷增加是機械人工呼吸器市場統計數據的主要促進因素。此外,全球新冠肺炎疫情導致死亡率、發病率和醫療保健成本上升,進一步推動了市場成長。因此,各醫療機構都在專注於感染控制和預防,以最大限度地減少這些呼吸系統疾病的病例數。例如,根據美國國家老齡委員會的數據,阻塞型睡眠呼吸中止症症候群(OSA)的特徵是呼吸不規則和大腦供氧減少,在美國約有3900萬成年人患有此病,全球估計有9.36億人患有此病。此外,根據美國肺臟協會的數據,慢性阻塞性肺病(COPD)是美國第三大疾病死因。超過1640萬人已被診斷出患有慢性阻塞性肺病。
技術進步
機械人工呼吸器技術的不斷進步,例如便攜性、模式和使用者介面的改進,正在擴大人工呼吸器市場。此外,受居家醫療新趨勢的推動,攜帶式和易用型設備在家庭環境中的日益普及,也促進了全球市場的發展。同時,具備自動化和先進監測功能的智慧機械人工呼吸器的推出,也對市場成長產生了正面影響。例如,Max Ventilator推出了一款具有加濕和氧氣療法功能的非侵入性機械人工呼吸器,展現了其在成人和新生兒護理中的廣泛應用。此外,日本光電OrangeMed的NKV-330機械人工呼吸器系統已獲得FDA核准,該系統為非侵入性呼吸機,可提供緊急呼吸支援。
政府主導的計劃開始
全球各國政府機構推出的眾多舉措和項目,包括旨在意識提升對呼吸系統疾病及其早期發現和治療重要性的認知的公共衛生宣傳活動,正對機械人工呼吸器市場前景產生積極影響。此外,監管機構加大對研發的投入,用於推出最新改良型機械人工呼吸器,也推動了市場成長。同時,醫療基礎設施的進步,以及針對醫護人員的培訓計畫和研討會的增加,進一步促進了機械人工呼吸器市場的收入成長。例如,CAIRE公司的「FreeStyle Comfort」可攜帶式氧氣設備已在法國和德國核准醫保報銷,提高了患者的就醫便利性。該產品的上市進一步拓展了該公司在氧氣療法領域的產品系列。此外,CorVent Medical公司已獲得CE核准,並在歐洲開始銷售其「RESPOND-19」機械人工呼吸器。這款創新系統在設計時充分考慮了易用性和重症監護通氣能力的靈活擴展,有助於醫院改善急性呼吸窘迫症候群(ARDS)重症患者的治療。
The global mechanical ventilators market size reached USD 5.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 8.3 Billion by 2034, exhibiting a growth rate (CAGR) of 3.70% during 2026-2034. The market is primarily driven by the rising prevalence of chronic obstructive pulmonary disease (COPD) and respiratory disorders, the elevating number of individuals suffering from hypertension, diabetes, and cardiovascular diseases, and the continuous technological advancements, such as the development of non-invasive and portable mechanical ventilators.
Increasing Cases of Chronic Respiratory Conditions
The rising cases of chronic respiratory conditions, including asthma, acute obstructive pulmonary disease, and pneumonia are primarily driving the mechanical ventilators market statistics. Moreover, the outbreak of the COVID-19 pandemic across the globe had increased mortality, morbidity, and healthcare costs, which is propelling the market growth forward. Therefore, various medical facilities are focusing highly on control measures and infection prevention to minimize the cases of such respiratory diseases. For instance, the National Council on Aging data indicated that Obstructive Sleep Apnea (OSA), characterized by irregular breathing and reduced oxygen supply to the brain, affected about 39 million adults in the U.S. and an estimated 936 million globally. Additionally, as per the American Lung Association, chronic obstructive pulmonary disease (COPD) is the third leading cause of death by disease in the United States. More than 16.4 million people have been diagnosed with chronic obstructive pulmonary disease.
Technological Advancements
The ongoing technological advances, such as improved ventilator portability, modes, and user interfaces, are augmenting the mechanical ventilators market. Moreover, the growing popularity of portable and user-friendly devices in home settings, on account of the emerging trend of home-based medical care, is catalyzing the global market. Besides this, the introduction of smart mechanical ventilator variants with automated features and advanced monitoring capabilities is also positively influencing the market growth. For example, Max Ventilator introduced non-invasive ventilators featuring humidifiers and oxygen therapy capabilities, demonstrating versatility in applications for adult and neonatal care. Additionally, Nihon Kohden OrangeMed, Inc. received U.S. FDA clearance for the NKV-330 Ventilator System, which is non-invasive and provides respiratory support in emergencies.
Launch of Government Initiatives
The launch of several policies and initiatives by government bodies across countries, including public health campaigns to raise awareness about respiratory illnesses and the importance of early detection and treatment is positively influencing the mechanical ventilators market outlook. In addition to this, the inflating investments by regulatory authorities in research and development efforts for the introduction of the latest and improved mechanical ventilators are also propelling the market expansion. Moreover, the advancing healthcare infrastructures, along with the increasing number of training programs and seminars for medical professionals are further catalyzing the mechanical ventilators market revenue. For instance, CAIRE Inc.'s FreeStyle Comfort portable oxygen concentrator was authorized for reimbursement in France and Germany, enhancing patient access. The company extended its oxygen therapy modalities product portfolio through this launch. Furthermore, CorVent Medical received CE Mark approval and launched commercial use of its RESPOND-19 Ventilator in Europe. The novel system is designed for easy-to-use, flexible expansion of critical care ventilation capacity to allow hospitals to improve the treatment of critically ill patients suffering from acute respiratory distress syndrome (ARDS).
Intensive care ventilators are developed for usage in critical care settings, such as intensive care units (ICUs) and emergency departments. They are capable of offering an advanced respiratory support to patients with severe respiratory failure or other critical conditions. On the other hand, portable/ambulatory ventilators are designed for use outside of traditional hospital settings, including in-home care, ambulances, or other transport settings. They are smaller, lighter, and more portable than intensive care variants, making them suitable for use in various places.
Invasive ventilation typically comprises the insertion of a tube into the patient's airway, usually through the mouth or nose (endotracheal tube) or via a surgical opening in the neck (tracheostomy tube). This allows the ventilator to deliver air or oxygen directly into the lungs. Invasive ventilation is generally utilized for patients with severe respiratory failure or who are unable to breathe on their own. Moreover, non-invasive ventilation does not need the insertion of a tube into the airway of the individual. Instead, it uses a mask or similar device to deliver air or oxygen to the patient's lungs. Non-invasive ventilation is often used for patients with less severe respiratory failure or for patients who are able to breathe on their own but require the additional support.
Pediatric ventilators are specifically created for infants and children. They are smaller in size and have features that cater to the unique respiratory needs of pediatric patients. These devices often include specialized modes and settings to deliver the appropriate level of support for smaller lungs and airways. Besides this, adult ventilators are designed for use in adult patients. They are larger and more robust than pediatric derivatives and are capable of providing the higher tidal volumes and pressures demanded for adult respiratory support. On the other hand, geriatric patients, who are typically older adults, may require ventilator support, owing to age-related respiratory conditions or complications.
Combined mode of ventilation, also referred to as dual or hybrid mode, combines the aspects of volume and pressure ventilation. It allows the ventilator to adjust the inspiratory pressure to maintain a set tidal volume, providing a more flexible and adaptable ventilation. Moreover, in volume mode of ventilation, the ventilator supplies a set tidal volume to the patient with each breath. This mode is commonly used in patients with normal lung compliance or when precise control over tidal volume is required, such as in acute respiratory distress syndrome (ARDS). Besides this, in pressure mode of ventilation, the ventilator delivers a set inspiratory pressure to the individual, allowing for a more variable tidal volume based on the lung compliance and resistance of the patient.
In hospitals and clinics, mechanical ventilators are utilized in intensive care units (ICUs), emergency departments, operating rooms, and general wards to support patients with acute respiratory failure, respiratory distress, or other conditions that require assisted ventilation. Additionally, these devices are increasingly being used in homecare settings to provide long-term respiratory support to patients with chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD), neuromuscular disorders, or spinal cord injuries. Furthermore, ambulatory care centers, also known as outpatient clinics or day surgery centers, may utilize mechanical ventilators for patients undergoing procedures that require sedation or anesthesia, including endoscopic procedures or minor surgeries.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
North America represents a significant region of the mechanical ventilators market overview, owing to its advanced healthcare infrastructure and the inflating medical expenditures of individuals. Besides this, the increasing focus of Europe on healthcare quality and patient safety is further catalyzing the market forward. Moreover, in the Asia Pacific region, the rising aging population is positively influencing the market growth. Besides this, the inflating medical care spending by individuals in Latin America and Middle East and Africa and the increasing awareness towards respiratory diseases are augmenting the market expansion. For instance, according to a report published by the Centers for Disease Control and Prevention (CDC), out of all the hospitalizations caused by COVID-19, over 53% of patients were admitted to the intensive care unit. Additionally, based on a research study by Silvio A. Namendys-Silva et al., published in Critical Care, in Mexico, about 15.3% of hospitalized patients require invasive mechanical ventilation (IMV), and 70.8% of patients receive invasive mechanical ventilation (IMV) outside the ICU.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the major market players in the Mechanical Ventilators industry include:
()